
Gian Life Care Ltd Reschedules Board Meeting to Approve Q3 Results for FY2025-26
Gian Life Care Ltd has informed the BSE that the meeting of the Board of Directors, originally scheduled for January 24, 2026, has been rescheduled to January 28, 2026. The primary agenda of the meeting remains unchanged, which includes the consideration and approval of the unaudited standalone and consolidated financial results for the quarter or period ended September 30, 2025. The trading window for dealing in shares of the company has been closed for Directors, KMP's, Designated Employees, and Connected Persons from October 1, 2025, and will remain closed till 48 hours after the information is made public.
Key Highlights
- Gian Life Care Ltd reschedules Board meeting to January 28, 2026
- To consider and approve unaudited standalone and consolidated financial results for Q3 FY2025-26
- Trading window for dealing in shares closed from October 1, 2025, for Directors, KMP's, Designated Employees, and Connected Persons
Price Impact
More from GIANLIFE
Gian Life Care Ltd Enters Hospital Lab Management Services Agreement with Brahma Hospital (HUF)
Gian Life Care Ltd Announces Q3 2025 Results with ¥ 743.78 Lakhs Cash Balance and Unpaid Dues
Gian Life Care Ltd. Approves Q3 Results with Cash Balance of ₹ 743.78 Lakhs and Unpaid Dues of ₹ 426.66 Lakhs and ₹ 359.78 Lakhs